# 75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)

> **NCT00140465** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 60 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT00140465
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2007-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140465, "75 or 150 mg Clopidogrel Maintenance Doses Following PCI (ISAR-CHOICE-2)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00140465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*